Apixaban Discontinuation Prior to Major Surgery

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

September 30, 2018

Conditions
HemorrhageThromboembolism
Interventions
OTHER

Lab tests for plasma levels of apixaban and anti-10a factor

All patients will have a blood draw at 48 hours prior to elective surgical procedure and then a second blood draw on the morning of the procedure to test apixaban plasma and anti-Xa levels.

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Thomas Jefferson University

OTHER